ERBB2 and melanoma: Thus, in melanoma, one sample (6.2%) had an uncommon BRAF (c.1400C>T; p.Ser467Leu) mutation, one (6.2%) had an NRAS (c.385C>T; p.Gln129*) mutation, and rare EGFR, ERBB2, KRAS, and MET mutations were also exhibited in one sample (6.2%).